Machine Learning for Precision Oncology in Pancreatic Disease

We are integrating molecular, clinical, and metabolic datasets using advanced machine learning algorithms to identify clinically meaningful subgroups, predict patient outcomes, and stratify therapeutic risk. This effort supports personalized treatment planning, optimization of clinical trial design, and the development of precision medicine pipelines specific to pancreatic cancer.